<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Traumatology and Orthopedics of Russia</journal-id><journal-title-group><journal-title xml:lang="en">Traumatology and Orthopedics of Russia</journal-title><trans-title-group xml:lang="ru"><trans-title>Травматология и ортопедия России</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2311-2905</issn><issn publication-format="electronic">2542-0933</issn><publisher><publisher-name xml:lang="en">Vreden National Medical Research Center of Traumatology and Orthopedics</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1300</article-id><article-id pub-id-type="doi">10.21823/2311-2905-2019-25-3-81-83</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="zh"><subject>Clinical studies</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Comment on the Article “The Effect of Pharmacological Thromboprophylaxis, Tourniquet and Drainage on Hemorrhagic Complications in the Early Stage after Knee Arthroplasty: Preliminary Results”</article-title><trans-title-group xml:lang="ru"><trans-title>Комментарий к статье «Влияние фармакологической тромбопрофилактики, турникета и дренирования на геморрагические осложнения в ранние сроки после эндопротезирования коленного сустава: предварительные результаты»</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Belov</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Белов</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Head of Department of Arthroplasty; Associate professor, Department of Traumatology and Orthopedics</p><p>Yaroslavl</p></bio><bio xml:lang="ru"><p>канд. мед. наук, заведующий отделением эндопротезирования; доцент кафедры травматологии и ортопедии</p><p>Ярославль</p></bio><email>micbelov@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Solovyеv Clinical Hospital,&#13;
Yaroslavl State Medical University</institution></aff><aff><institution xml:lang="ru">ГАУЗ ЯО «Клиническая больница скорой медицинской помощи им. Н.В. Соловьева»,&#13;
ФГБОУ ВО «Ярославский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-10-18" publication-format="electronic"><day>18</day><month>10</month><year>2019</year></pub-date><volume>25</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>81</fpage><lpage>83</lpage><history><date date-type="received" iso-8601-date="2019-10-16"><day>16</day><month>10</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-10-16"><day>16</day><month>10</month><year>2019</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://journal.rniito.org/jour/article/view/1300">https://journal.rniito.org/jour/article/view/1300</self-uri><abstract xml:lang="en"><p>.</p></abstract><trans-abstract xml:lang="ru"><p>.</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Liu J., Zhao J., Yan Y., Su J. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(9):e14539. doi: 10.1097/MD.0000000000014539.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Memtsoudis S.G., Pumberger M., Ma Y., Chiu Y.L., Fritsch G., Gerner P. et al. Epidemiology and risk factors for perioperative mortality after total hip and knee arthroplasty. J Orthop Res. 2012;30(11):1811-1821. doi: 10.1002/jor.22139.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Kinov P., Tanchev P.P., Ellis M., Volpin G. Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations. Int Orthop. 2014;38(1):169-175. doi: 10.1007/s00264-013-2134-8.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Профилактика венозных тромбоэмболических осложнений в травматологии и ортопедии. Российские клинические рекомендации. Травматология и ортопедия России. 2012;1(приложение):2-24.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Markovic-Denic L., Zivkovic K., Lesic A., Bumbasirevic V., Dubljanin-Raspopovic E., Bumbasirevic M. Risk factors and distribution of symptomatic venous chromboembolism in total hip and knee replacements: prospective study. Int Orthop. 2012;36(6):1299-1305. doi: 10.1007/s00264-011-1466-5.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Falck-Ytter Y., Francis C.W., Johanson N.A., Curley C., Dahl O.E., Schulman S. [et al.] Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S-e325S. doi: 10.1378/chest.11-2404.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Anderson D.R., Dunbar M., Murnaghan J., Kahn S.R., Gross P., Forsythe M. et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018;378(8):699-707. doi: 10.1056/NEJ Moa1712746.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355(9212):1295-1302. doi: 10.1016/S0140-6736(00)02110-3.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Anderson D.R., Dunbar M.J., Bohm E.R., Belzile E., Kahn S.R., Zukor D. et al. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med. 2013;158(11):800-806. doi: 10.7326/0003-4819-158-11-201306040-00004.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Arsoy D., Giori N.J., Woolson S.T. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA. Clin Orthop Relat Res. 2018;476(2):381-387. doi: 10.1007/s11999.0000000000000041.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Yhim H.Y., Lee J., Lee J.Y., Lee J.O., Bang S.M. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study. PLoS One. 2017;12(5):e0178214. doi: 10.1371/journal.pone.0178214.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Alcelik I., Pollock R.D., Sukeik M., Bettany-Saltikov J., Armstrong P.M., Fismer P. A comparison of outcomes with and without a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty. 2012;27(3):331-340. doi: 10.1016/j.arth.2011.04.046.</mixed-citation></ref></ref-list></back></article>
